Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Phathom Pharmaceuticals Inc

PHAT
Current price
8.78 USD -0.35 USD (-3.83%)
Last closed 9.09 USD
ISIN US71722W1071
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 152 843 008 USD
Yield for 12 month +19.78 %
1Y
3Y
5Y
10Y
15Y
PHAT
21.11.2021 - 28.11.2021

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey. Address: 100 Campus Drive, Florham Park, NJ, United States, 07932

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

25.29 USD

P/E ratio

Dividend Yield

Current Year

+682 000 USD

Last Year

Current Quarter

+16 352 000 USD

Last Quarter

+7 324 000 USD

Current Year

+515 000 USD

Last Year

-620 000 USD

Current Quarter

+13 996 000 USD

Last Quarter

+5 948 000 USD

Key Figures PHAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -287 137 984 USD
Operating Margin TTM -432.95 %
PE Ratio
Return On Assets TTM -57.67 %
PEG Ratio
Return On Equity TTM -3489 %
Wall Street Target Price 25.29 USD
Revenue TTM 26 270 000 USD
Book Value -2.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -5.74 USD
Diluted Eps TTM -5.74 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PHAT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PHAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation PHAT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 37.8597
Price Sales TTM 43.8844
Enterprise Value EBITDA -2.2043
Price Book MRQ 25.3678

Financials PHAT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PHAT

For 52 weeks

6.07 USD 19.71 USD
50 Day MA 17.28 USD
Shares Short Prior Month 17 219 985
200 Day MA 12.06 USD
Short Ratio 15.67
Shares Short 17 555 904
Short Percent 36.3 %